Health ❯Healthcare ❯Clinical Trials

Phase III Trials

Efficacy Studies MDMA Trials MinervaX GBS Vaccine FRESCO-2 Trial Induction Chemotherapy Interlace Trial GALAXI Trials COMBI-AD Study Weight Loss Efficacy CENTERSTONE Trial Orforglipron Immunological Response BREAKWATER Trial Dietary Interventions ENPP1 Deficiency Treatments Atezolizumab HIMALAYA Trial Serena-6 Trial ASPEN Trial HD21 Trial ASPEN Study OLIGUITO Study OLYMPIA Trials Aceclidine Studies

FDA Approves Brensocatib as First Treatment for Non-Cystic Fibrosis Bronchiectasis

Insmed plans 2026 launches across key markets with an $88,000 annual list price following FDA clearance.

FDA Approves IL-23 Inhibitor Tremfya for Moderate-to-Severe Crohn’s Disease

Anti-Inflammatory Diet and Exercise Associated with Better Survival in Stage III Colon Cancer

Atezolizumab-Enhanced Chemotherapy Halves Recurrence in Stage III dMMR Colon Cancer

Triplet Therapy Doubles Survival in BRAF V600E Metastatic Colorectal Cancer

Moderna’s Combined COVID-19 and Flu Vaccine Shows Promising Phase III Results

Single-Dose Flu Drug Proven to Reduce Household Transmission by 30%

Novo Nordisk Seeks FDA Approval as Eli Lilly's Weight-Loss Pill Advances

New Blood Test Accurately Predicts Melanoma Recurrence in Stage III Patients

New Cervical Cancer Treatment Reduces Death Risk by 40%

FDA Declines MDMA for PTSD Treatment, Requests Further Trials